With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.163765-44-4,(R)-1-Boc-3-Methylpiperazine,as a common compound, the synthetic route is as follows.
Compound (R) – 3-methyl-piperazine-1-carboxylic acid T-butyl ester (530 mg, 2 . 6mmol), compound quinoline-2-carboxylic acid (450 mg, 2 . 6mmol), 1-ethyl-3 – (3-dimethylamino-propyl) carbodiimide hydrochloride (996 mg, 5 . 2mmol) and N-hydroxy-7-azabenzene and triazazole (530 mg, 3 . 9mmol) dissolved in dichloromethane (10 ml) in, 0 C to this solution under the conditions of adding dropwisely N, N-diisopropyl ethylamine (1.3 ml, 7 . 8mmol), stirring the mixture at room temperature for 10h, and washing with water (10 ml × 3), the organic phase is dried with anhydrous sodium sulfate, removal of solvent, concentrate under column separation (V (petroleum ether)/ V (ethyl acetate) =1/1) get 820 mg white solid, yield: 88%., 163765-44-4
163765-44-4 (R)-1-Boc-3-Methylpiperazine 2756811, apiperazines compound, is more and more widely used in various fields.
Reference：
Patent; Guangdong East Sunshine Pharmaceutical Co., Ltd.; Yu, Tianzhu; Liu, Bing; Zhang, Yingjun; Zhang, Xiangyu; Zhang, Zhiguo; Zheng, Changchun; Zhang, Jiancun; Lei, Jianhua; (66 pag.)CN105461693; (2016); A;,
Piperazine – Wikipedia
Piperazines – an overview | ScienceDirect Topics